Live
- Chintamaneni Prabhakar Promises Security and Welfare for Poor Families with Babu's Super 6 Schemes
- J&K Police file case against attempt to disrespect place of worship
- Velampalli Srinivasa Rao Seeks Votes in 61st Division, Slams Opposition Parties
- Major Development Projects Completed in Bhimavaram Town by MLA Grandhi Srinivas
- Vice Prez offers prayers in Tirumala temple
- Tech Mahindra shares jump more than 8 per cent on turnaround strategy
- Long queues outside polling booths in Jammu-Reasi LS constituency
- Indian startups file 83,000 patents in FY23; AI, neurotechnology lead
- 31.77 pc polling in Maharashtra's 8 seats till 1 p.m.
- Ukrainian minister remanded in custody after corruption allegations
Just In
Evidence should inform policy: Should we offer antiretroviral therapy soon after HIV diagnosis?
There are over 1 million new TB cases in people living with HIV (PLHIV) and 320,000 HIV/TB deaths every year. Moreover HIV increases the risk of getting TB manifold - PLHIV have an annual 5%-15% risk of acquiring TB infection as against is 5%-15% lifetime risk in HIV negative persons.
There are over 1 million new TB cases in people living with HIV (PLHIV) and 320,000 HIV/TB deaths every year. Moreover HIV increases the risk of getting TB manifold - PLHIV have an annual 5%-15% risk of acquiring TB infection as against is 5%-15% lifetime risk in HIV negative persons.
Challenges to concurrent HIV and TB therapy - like pill burden, overlapping drug toxicities, pharmacokinetic of drug-drug interactions, increased risk of immune restoration disease - have led to debates on when to initiate ART in patients with newly diagnosed HIV infection and TB. However, results of a few important studies produce strong evidence to improve treatment outcomes for PLHIV as well as to protect them from co-infections like TB.
© 2024 Hyderabad Media House Limited/The Hans India. All rights reserved. Powered by hocalwire.com